MariMed Financial Results - The Cannabis Investor

MariMed Announces Strong Q1 2019 Earnings, Revenue and Adjusted EBITDA Jump 69% and 76% Respectively

Significant improvement in operating performance – Revenue up 69%; Adjusted EBITDA up 76% Planned consolidation of cannabis operations under MariMed banner advancing on schedule The launch of MariMed Hemp operations including the development of CBD brands and products Conversion of debt investment... read more →

May 13, 2019
Ryan T.

MariMed Reports Q4 and Full Year 2018 Financial Results, Q4 Revenue Surges 118%

Fourth Quarter 2018: 118% Year-Over-Year Revenue Growth Fiscal 2018: 95% Revenue Year-Over-Year Growth; Adjusted EBITDA up 53% Strategic Investments Position MariMed for Dynamic Growth in Cannabis and Hemp CBD NORWOOD, April 17, 2019 (GLOBE NEWSWIRE) -- – MariMed Inc. (OTCQB: MRMD) one of the largest multi-state cannabis... read more →